Evidence map›Paper›PMID 30825062›Full record

ArticleJournal of neuro-oncology2019

Multiplex ligation-dependent probe amplification analysis is useful for detecting a copy number gain of the FGFR1 tyrosine kinase domain in dysembryoplastic neuroepithelial tumors.

Nozomi Matsumura, Sumihito Nobusawa, Junko Ito, Akiyoshi Kakita, Hiroyoshi Suzuki, Yukihiko Fujii, Masafumi Fukuda, Masaki Iwasaki, Nobukazu Nakasato, Teiji Tominaga and 7 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neuro-oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Long-term follow-up of dysembryoplastic neuroepithelial tumour (DNET) with recurrent bleeds: a case report and review of literature.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2026
    Review
  2. Review
  3. Article
  4. Case Report: A novelFrontiers in oncology · 2022
    Article
  5. Review
  6. Review
  7. Pediatric low-grade glioma in the era of molecular diagnostics.Acta neuropathologica communications · 2020
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Nozomi MatsumuraDepartment of Human Pathology, Gunma University Graduate School of Medicine, 3-39-22, Showa-machi, Maebashi, Gunma, 371-8511, Japan. nozomim@gunma-u.ac.jp.ORCID http://orcid.org/0000-0001-6592-6582
Sumihito NobusawaDepartment of Human Pathology, Gunma University Graduate School of Medicine, 3-39-22, Showa-machi, Maebashi, Gunma, 371-8511, Japan.
Junko ItoDepartment of Pathology, Brain Research Institute, Niigata University, Niigata, Niigata, Japan.
Akiyoshi KakitaDepartment of Pathology, Brain Research Institute, Niigata University, Niigata, Niigata, Japan.
Hiroyoshi SuzukiDepartment of Pathology and Laboratory Medicine, National Hospital Organization Sendai Medical Center, Sendai, Miyagi, Japan.
Yukihiko FujiiDepartment of Neurosurgery, Brain Research Institute, Niigata University, Niigata, Niigata, Japan.
Masafumi FukudaDepartment of Neurosurgery, Nishi-Niigata Chuo National Hospital, Niigata, Niigata, Japan.
Masaki IwasakiDepartment of Neurosurgery, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan.
Nobukazu NakasatoDepartment of Epileptology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
Teiji TominagaDepartment of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
Atsushi NatsumeDepartment of Neurosurgery, Nagoya University School of Medicine, Nagoya, Aichi, Japan.
Yoshiki MikamiDepartment of Diagnostic Pathology, Kumamoto University Hospital, Kumamoto, Kumamoto, Japan.
Naoki ShinojimaDepartment of Neurosurgery, Kumamoto University Hospital, Kumamoto, Kumamoto, Japan.
Tatsuya YamazakiDepartment of Human Pathology, Gunma University Graduate School of Medicine, 3-39-22, Showa-machi, Maebashi, Gunma, 371-8511, Japan.
Yoichi NakazatoDepartment of Pathology, Hidaka Hospital, Takasaki, Gunma, Japan.
Junko HiratoDepartment of Diagnostic Pathology, Gunma University Hospital, Maebashi, Gunma, Japan.
Hideaki YokooDepartment of Human Pathology, Gunma University Graduate School of Medicine, 3-39-22, Showa-machi, Maebashi, Gunma, 371-8511, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeDysembryoplastic neuroepithelial tumors (DNTs) are slow-growing glioneuronal tumors, and their genetic backgrounds are getting unveiled. Recently, fibroblast growth factor receptor 1 internal tandem duplication (FGFR1-ITD) of the tyrosine kinase domain (TKD) has been demonstrated by whole-genome sequencing. METHODS AND

resultsHere, we analyzed 22 DNTs using multiplex ligation-dependent probe amplification (MLPA) with formalin-fixed paraffin-embedded specimens and found a copy number gain in TKD of FGFR1 (13 cases, 59%), which suggested the presence of FGFR1-ITD. Another 5 DNTs harbored FGFR1 hot spot mutations including a double mutant case, and FGFR1 alterations were detected in 18 DNTs (82%). The BRAF V600E mutation, another important mutation in DNTs, was not observed.

conclusionsWith recent findings of less frequent or absent FGFR1-ITD in pilocytic astrocytomas or rosette-forming glioneuronal tumors, the analysis of FGFR1 aberrations, especially FGFR1-ITD, was suggested to be helpful to discriminate DNTs from their histological mimics.

Indexed as

DNA Copy Number VariationsMultiplex Polymerase Chain ReactionMutationAdolescentAdultBiomarkers, TumorChildChild, PreschoolClass I Phosphatidylinositol 3-KinasesFemaleHumansMaleMiddle AgedNeoplasms, NeuroepithelialProtein DomainsProto-Oncogene Proteins B-rafBiomarkers, TumorBRAF protein, humanClass I Phosphatidylinositol 3-KinasesFGFR1 protein, humanPIK3CA protein, humanProto-Oncogene Proteins B-rafReceptor, Fibroblast Growth Factor, Type 1DNTFFPEFGFR1 alterationFGFR1-ITDMLPA

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.